Aurinia Pharmaceuticals Inc. (AUPH): 5 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Jun 2, 2026 | Tang Kevin Director, Officer, TenPercentOwner | 814,606 | $15.29 | $12.5M | no history |
| Mar 3, 2026 | Tang Kevin Director | 900,000 | $14.10 | $12.7M | no history |
| Aug 5, 2025 | Tang Kevin Director | 1,300,000 | $10.45 | $13.6M | no history |
| Mar 4, 2025 | Tang Kevin Director | 1,600,000 | $7.95 | $12.7M | no history |
| Dec 9, 2024 | Tang Kevin Director | 1,200,000 | $9.02 | $10.8M | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.